Split Creek Capital’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$263K Buy
+485
New +$251K 0.25% 117
2026
Q2
– Sell
-426
Closed -$253K – 145
2026
Q1
$253K Sell
426
-58
-12% -$28.9K 0.27% 105
2025
Q4
$236K Buy
+484
New +$225K 0.25% 118

Other funds holding UTHR

Split Creek Capital's UTHR Position: Q3 2026 in Review

Split Creek Capital opened a new position in United Therapeutics (UTHR) in Q3 2026: 485 shares worth $263K. The stake represents 0.25% of the portfolio and ranks #117 among its holdings. This is a return to the name: Split Creek Capital previously reported a position in UTHR as recently as Q1 2026.

Split Creek Capital first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Split Creek Capital held 485 shares of United Therapeutics worth $263K as of Q3 2026.
  • United Therapeutics was a new Split Creek Capital position in Q3 2026.
  • United Therapeutics made up 0.25% of Split Creek Capital's portfolio in Q3 2026, its #117 holding.
  • Split Creek Capital first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.